Oruka Therapeutics CMO Disposes $313K in Shares as Clinical Momentum Draws Analyst Attention
Oruka Therapeutics Chief Medical Officer Joana Goncalves sold 7,641 shares of company stock on March 16, 2026, under a pre-arranged 10b5-1 plan for roughly $312,559, while also exercising options for 7,000 shares. The transactions leave Goncalves with direct ownership of 33,377 shares. The moves come as the stock trades near a 52-week high and as O…